Upstream Bio (UPB) Cash from Financing Activities (2023 - 2026)

Upstream Bio's Cash from Financing Activities history runs 4 years deep, the most recent figure standing at $598000.0 for Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 1858.82% year-over-year to $598000.0; the TTM figure through Mar 2026 stood at $3.1 million (down 99.25% YoY), while the FY2025 annual figure was $2.4 million, down 99.42% from the prior year.
• Cash from Financing Activities was $598000.0 for Q1 2026 at Upstream Bio, down from $1.1 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $270.6 million in Q4 2024 to a low of -$1.6 million in Q3 2024.
• Historically, Cash from Financing Activities has averaged $42.2 million across 4 years, with a median of $686000.0 in 2025.
• The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities soared 203594.74% in 2024, then slumped 100.36% in 2025.
• A 4-year view of Cash from Financing Activities shows it stood at -$133000.0 in 2023, then jumped by 203594.74% to $270.6 million in 2024, then tumbled by 99.59% to $1.1 million in 2025, then sank by 45.78% to $598000.0 in 2026.
• The last three Cash from Financing Activities figures came in at $598000.0 (Q1 2026), $1.1 million (Q4 2025), and $760000.0 (Q3 2025), per Business Quant data.